The historical rank and industry rank for Guardant Health's Days Sales Outstanding or its related term are showing as below:
GH'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 50.52 Med: 67.85 Max: 97.61
Current: 58.06
During the past 8 years, Guardant Health's highest Days Sales Outstanding was 97.61. The lowest was 50.52. And the median was 67.85.
GH's Days Sales Outstanding is ranked better than 69.06% of 223
companies
in the Medical Diagnostics & Research industry
Industry Median: 69.32
vs GH: 58.06
Guardant Health's Days Sales Outstanding
declined
from Dec. 2022 (65.96) to Dec. 2023 (52.25).
Guardant Health Days Sales Outstanding Historical Data
The historical data trend for Guardant Health's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Guardant Health's Days Sales Outstanding
For the Diagnostics & Research subindustry, Guardant Health's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guardant Health's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Guardant Health's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Guardant Health's Days Sales Outstanding falls into.
Guardant Health Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guardant Health (NAS:GH) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Guardant Health Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Guardant Health's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Guardant Health (Guardant Health) Business Description
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GH has been successfully added to your 